Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ.
Sign Up to like & getrecommendations! Published in 2017 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2017.04.013
Abstract: Phosphoinositide 3-kinases PI3Ks are major drug targets in oncology. Their role is far from being completely understood in pancreatic ductal adenocarcinoma. Pancreatic cancer is a dismal disease with limited therapeutic options except for surgery. We… read more here.
Keywords: pi3k; attenuating pi3k; isoforms pancreatic; pancreatic cancer ... See more keywords